The director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, resigned on ...
Trump administration officials pledged Monday that major reforms for biosimilar drug approvals will expand access and lower ...
The U.S. FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, ...
The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused ...
1don MSN
FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’ about his conduct
The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal officials began reviewing ...
An alleged extortion attempt, a petty yearslong grudge, shocking social media posts, and ominous text messages make up the ...
It was the latest shockwave to sweep through an agency beset by all kinds of tumult in recent months. In interviews, ...
Dr. George Tidmarsh, the Food and Drug Administration’s top drug regulator, was placed on administrative leave and is considering resigning, citing a “toxic” environment.
The U.S. Food and Drug Administration (FDA) announced that more than 140,000 bottles of a widely used generic cholesterol drug, atorvastatin calcium, are being voluntarily recalled because they ...
FDA's digital advisors could nudge the agency to clarify how its rules apply to medical applications of generative AI, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback